BioPharma Dive - Latest News

GSK to buy liver disease drug for $1.2B

The new acquisition from Boston Pharmaceuticals adds to a wave of dealmaking undertaken by GSK to build its liver disease franchise.

May 14, 2025 - 16:24
 0
GSK to buy liver disease drug for $1.2B

The new acquisition from Boston Pharmaceuticals adds to a wave of dealmaking undertaken by GSK to build its liver disease franchise.

Read More

Tags:

Previous Article

Siemens Healthineers to move some Varian manufacturing to California

Next Article

Trump Administration to Uphold Some PFAS Limits but Eliminate Others

Related Posts

PTC stock slides on new data for Huntington’s drug

PTC stock slides on new data for Huntington’s drug

May 5, 2025  0

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.

Biotech is guessing how Vinay Prasad might change the F...

May 8, 2025  0

FDA set to meet this month on COVID vaccines

FDA set to meet this month on COVID vaccines

May 7, 2025  0